Community Opioid Intervention Prevention Program | HHS 2024 IHS COIPP 0001

Community Opioid Intervention Prevention Program (COIPP) FAQs

1) What is the Community Opioid Intervention Prevention Program (COIPP)?

COIPP is a discretionary grant opportunity from the Indian Health Service (IHS) intended to help American Indian and Alaska Native (AI/AN) communities respond to the opioid crisis. It supports community-driven work to prevent opioid misuse, expand access to effective treatment for opioid use disorder, support long-term recovery, and reduce overdose harms.

2) What is the main purpose of the COIPP grant?

The program is meant to help Tribal and Urban Indian communities build or scale opioid-related services in ways that fit local culture, community priorities, and existing health and social systems.

3) What types of activities does COIPP support?

Based on the funding description, COIPP supports efforts that strengthen local approaches across prevention, treatment, recovery, and harm reduction. This includes community education, culturally appropriate interventions, increased use of medications for opioid use disorder, and strategies to reduce overdose harms.

4) What are the four core aims of COIPP?

The opportunity lists four core aims:

• Develop and expand community education and awareness related to opioid misuse and opioid use disorder, including prevention, treatment options, and recovery supports.
• Increase the knowledge and use of culturally appropriate interventions and encourage greater use of medication-assisted treatment/medications for opioid use disorder (MAT/MOUD).
• Bolster Tribal and Urban Indian communities in providing prevention, treatment, and recovery services that address the opioid crisis and its broader impacts on families and communities.
• Implement harm reduction strategies that lower overdose risk and other negative outcomes, including when individuals are not ready or able to stop using substances.

5) Does COIPP include harm reduction?

Yes. The notice explicitly includes harm reduction and encourages applicants to implement strategies that reduce overdose risk and other negative outcomes, even when people are not yet ready or able to stop using substances.

6) Does COIPP support treatment, including medications for opioid use disorder?

Yes. One of the core aims emphasizes encouraging greater use of medication-assisted treatment/medications for opioid use disorder (MAT/MOUD), alongside culturally appropriate interventions.

7) Who is eligible to apply for COIPP?

Eligibility is limited to specific AI/AN-serving entities as defined in federal statute (25 U.S.C. 1603). Eligible applicants include federally recognized Indian Tribes, Tribal organizations, and Urban Indian Organizations (UIOs), as described in the opportunity information.

8) Which Tribes are considered eligible under this opportunity?

Federally recognized Indian Tribes are eligible, as defined at 25 U.S.C. 1603(14). This includes Tribes, bands, nations, and other organized Native groups or communities, including Alaska Native villages and certain Alaska Native corporations recognized as eligible for federal Indian programs and services.

9) What is a Tribal organization for purposes of eligibility?

A Tribal organization (25 U.S.C. 1603(26)) can include the recognized governing body of a Tribe or a legally established Indian organization that is controlled, sanctioned, chartered, or democratically elected by the community it serves. The description also indicates strong expectations for meaningful Indian participation in all phases of the organization's work.

10) If a Tribal organization applies on behalf of multiple Tribes, what approvals are required?

If a Tribal organization applies to serve more than one Tribe, approvals from each Tribe are required. The funding notice specifies that letters of support and/or Tribal Resolutions must be submitted from the Tribes to be served.

11) Are Urban Indian Organizations (UIOs) eligible to apply?

Yes. Urban Indian Organizations (UIOs) are listed as eligible applicants under 25 U.S.C. 1603(29).

12) What qualifies an organization as an eligible Urban Indian Organization (UIO) under COIPP?

The opportunity describes a UIO as a nonprofit corporate body located in an urban center, governed by an Urban Indian-controlled board, structured to ensure maximum participation from interested Indian groups and individuals, and capable of legally partnering with public and private entities to carry out authorized activities.

13) What documentation must a UIO include with its application?

UIO applicants must include proof of nonprofit status with the application, such as documentation of 501(c)(3) status.

14) What agency is sponsoring COIPP?

The sponsoring agency is the Indian Health Service (IHS).

15) What is the funding opportunity number for COIPP?

The Funding Opportunity Number is HHS-2024-IHS-COIPP-0001.

16) What is the official funding opportunity title?

The Funding Opportunity Title is Community Opioid Intervention Prevention Program.

17) What type of funding instrument is COIPP?

COIPP is offered as a grant (FundingInstrumentType: Grant).

18) What is the CFDA/Assistance Listing number for this program?

The CFDA/Assistance Listing number is 93.654.

19) What is the program area/category for this opportunity?

The opportunity is listed under the health category.

20) What was the application closing date listed for this opportunity?

The original application closing date was February 7, 2024.

21) When was the opportunity record created?

The opportunity record was created on December 11, 2023.

22) What is the maximum award amount?

The anticipated maximum award amount (award ceiling) is $500,000.

23) How many awards were expected to be made?

The agency expected to make approximately 27 awards.

24) Is COIPP designed to be community-driven and culturally aligned?

Yes. The program emphasizes strengthening local, community-driven approaches and encourages culturally appropriate interventions that fit local culture and community priorities.

25) Does the opportunity focus only on clinical care?

No. While it encourages use of evidence-based clinical approaches like MAT/MOUD, the opportunity also highlights community education, culturally appropriate interventions, recovery support, and harm reduction as part of a broader community response.